PDF herunterladen
Dtsch Med Wochenschr 2012; 137(14): 738-744
DOI: 10.1055/s-0032-1304842
Kommentar | Commentary
Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Aktueller Stand der Behandlung von Vorhofflimmern

Treatment of atrial fibrillation – status quo
F. Straube
1   Klinikum Bogenhausen, Herzzentrum München-Bogenhausen, Klinik für Kardiologie und internistische Intensivmedizin, Städtisches Klinikum München GmbH
,
U. Dorwarth
1   Klinikum Bogenhausen, Herzzentrum München-Bogenhausen, Klinik für Kardiologie und internistische Intensivmedizin, Städtisches Klinikum München GmbH
,
M. Schmidt
1   Klinikum Bogenhausen, Herzzentrum München-Bogenhausen, Klinik für Kardiologie und internistische Intensivmedizin, Städtisches Klinikum München GmbH
,
E. Hoffmann
1   Klinikum Bogenhausen, Herzzentrum München-Bogenhausen, Klinik für Kardiologie und internistische Intensivmedizin, Städtisches Klinikum München GmbH
› Institutsangaben
Weitere Informationen

Publikationsverlauf

10. Januar 2012

08. März 2012

Publikationsdatum:
27. März 2012 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Schlüsselwörter

Vorhofflimmern - Antikoagulation - Ablation - Rhythmuskontrolle

Keywords

atrial fibrillation - anticoagulation - ablation - rythm control
 

  • Literatur

  • 1 Andrade JG, Khairy P, Guerra PG et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm 2011; 8: 1444-1451
    CrossrefPubMedGoogle Scholar
  • 2 Bai R, Horton RP, DI Biase L et al. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN Device: a single center experience. J Cardiovasc Electrophysiol 2011; DOI: DOI: 10.1111/ j.1540-8167.2011.02216.x.
    PubMedGoogle Scholar
  • 3 Bertaglia E, Tondo C, De Simone A et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. Europace 2010; 12: 181-187
    CrossrefPubMedGoogle Scholar
  • 4 Block PC, Burstein S, Casale PN et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc interv 2009; 2: 594-600
    CrossrefPubMedGoogle Scholar
  • 5 Bloomfield HE, Krause A, Greer N et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med 2011; 154: 472-482
    CrossrefPubMedGoogle Scholar
  • 6 Calkins H, Brugada J, Packer DL et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4: 816-861
    CrossrefPubMedGoogle Scholar
  • 7 Calkins H, Reynolds MR, Spector P et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009; 2: 349-361
    CrossrefPubMedGoogle Scholar
  • 8 Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38
    CrossrefPubMedGoogle Scholar
  • 9 Connolly SJ, Camm AJ, Halperin JL et al. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011; 365: 2268-2276
    CrossrefPubMedGoogle Scholar
  • 10 Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151
    CrossrefPubMedGoogle Scholar
  • 11 Eitel C, Piorkowski C, Hindricks G et al. Electrophysiology study guided by real-time magnetic resonance imaging. Eur Heart J 2011; DOI: DOI: 10.1093/eurheartj/ehr414.
    PubMedGoogle Scholar
  • 12 European Heart Rhythm Association, European Association for Cardio-Thoracic Society, . Camm AJ et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429
    CrossrefPubMedGoogle Scholar
  • 13 Fuster V, Ryden LE, Cannom DS et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011; 57: e101-198
    PubMedGoogle Scholar
  • 14 Granger CB, Alexander JH, McMurray JJ et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992
    CrossrefPubMedGoogle Scholar
  • 15 Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666
    CrossrefPubMedGoogle Scholar
  • 16 Hohnloser SH, Crijns HJ, van Eickels M et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009; 360: 668-678
    CrossrefPubMedGoogle Scholar
  • 17 Holmes DR, Reddy VY, Turi ZG et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009; 374: 534-542
    CrossrefPubMedGoogle Scholar
  • 18 Huda W, Schoepf UJ, Abro JA et al. Radiation-related cancer risks in a clinical patient population undergoing cardiac CT. AJR Am J Roentgenol 2011; 196: W159-165
    CrossrefPubMedGoogle Scholar
  • 19 Kanderian AS, Gillinov AM, Pettersson GB et al. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 2008; 52: 924-929
    CrossrefPubMedGoogle Scholar
  • 20 Kober L, Torp-Pedersen C, McMurray JJ et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008; 358: 2678-2687
    CrossrefPubMedGoogle Scholar
  • 21 Lakkireddy D, Reddy YM, Di Biase L et al. Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation Results From a Multicenter Prospective Registry. J Am Coll Cardiol 2012; DOI: DOI: 10.1016/j.jacc.2011.12.014.
    PubMedGoogle Scholar
  • 22 Lip GY, Nieuwlaat R, Pisters R et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272
    CrossrefPubMedGoogle Scholar
  • 23 Ouyang F, Tilz R, Chun J et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010; 122: 2368-2377
    CrossrefPubMedGoogle Scholar
  • 24 Park JW, Bethencourt A, Sievert H et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 2011; 77: 700-706
    CrossrefPubMedGoogle Scholar
  • 25 Patel MR, Mahaffey KW, Garg J et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891
    CrossrefPubMedGoogle Scholar
  • 26 Piccini JP, Lopes RD, Kong MH et al. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009; 2: 626-633
    CrossrefPubMedGoogle Scholar
  • 27 Piorkowski C, Hindricks G. Nonfluoroscopic sensor-guided navigation of intracardiac electrophysiology catheters within prerecorded cine loops. Circ Arrhythm Electrophysiol 2011; 4: e36-38
    CrossrefPubMedGoogle Scholar
  • 28 Pisters R, Lane DA, Nieuwlaat R et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138: 1093-1100
    CrossrefPubMedGoogle Scholar
  • 29 Rogers DP, England F, Lozhkin K et al. Improving safety in the electrophysiology laboratory using a simple radiation dose reduction strategy: a study of 1007 radiofrequency ablation procedures. Heart 2011; 97: 366-370
    CrossrefPubMedGoogle Scholar
  • 30 Schmidt M, Daccarett M, Marschang H et al. Intracardiac echocardiography improves procedural efficiency during cryoballoon ablation for atrial fibrillation: a pilot study. J Cardiovasc Electrophysiol 2010; 21: 1202-1207
    CrossrefPubMedGoogle Scholar
  • 31 Shah AN, Mittal S, Sichrovsky TC et al. Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol 2008; 19: 661-667
    CrossrefPubMedGoogle Scholar
  • 32 Tzou WS, Marchlinski FE, Zado ES et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 237-242
    CrossrefPubMedGoogle Scholar
  • 33 Venneri L, Rossi F, Botto N et al. Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: insights from the National Research Council's Biological Effects of Ionizing Radiation VII Report. Am Heart J 2009; 157: 118-124
    CrossrefPubMedGoogle Scholar
  • 34 Wann LS, Curtis AB, Ellenbogen KA et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2011; 57: 1330-1337
    CrossrefPubMedGoogle Scholar
  • 35 Wann LS, Curtis AB, Ellenbogen KA et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 123: 1144-1150
    CrossrefPubMedGoogle Scholar
  • 36 Wann LS, Curtis AB, January CT et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 57: 223-242
    CrossrefPubMedGoogle Scholar
  • 37 Weerasooriya R, Khairy P, Litalien J et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?. J Am Coll Cardiol 2011; 57: 160-166
    CrossrefPubMedGoogle Scholar
  • 38 Winkle RA, Mead RH, Engel G et al. The use of dabigatran immediately after atrial fibrillation ablation. J Cardiovasc Electrophysiol 2011; DOI: DOI: 10.1111/j.1540-8167.2011.02175. .
    PubMedGoogle Scholar
  • 39 Dorwarth U, Schmidt M, Wankerl M et al. Pulmonary vein electrophysiology during cryoballoon ablation as a predictor for procedural success. J Interv Card Electrophysiol 2011; 32: 205-211
    CrossrefPubMedGoogle Scholar